EUVIMEDEUVIMED entdecken
Open Access

Targeted disruption of the <italic>BCR-ABL</italic> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells

Jianling Zeng, Xinquan Liang, Lili Duan, Fenghua Tan, Liujie Chen, Jiayao Qu, Jia Li, Kai Li, Dixian Luo, Zheng Hu

Acta Biochimica et Biophysica Sinica · 2024

DOI: 10.3724/abbs.2023280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Jianling Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Institute, the First People's Hospital of Chenzhou, Hengyang Medical School, University of South China, Chenzhou 423000, China. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, RNA, Guide, CRISPR-Cas Systems. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveRNA, Guide, CRISPR-Cas SystemsAnimalsHumansMiceApoptosisCell ProliferationCRISPR-Cas SystemsFusion Proteins, bcr-ablGenes, ablProto-Oncogene Proteins c-bcr

Stichwörter der Autor:innen

CRISPR/Cas9apoptosiscell proliferationchronic myeloid leukemia (CML)dual sgRNA

Substanzen

Fusion Proteins, bcr-ablProto-Oncogene Proteins c-bcrRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Translational Medicine Institute, the First People's Hospital of Chenzhou, Hengyang Medical School, University of South China, Chenzhou 423000, China.
  • The First Affiliated Hospital of Xiangnan University, Chenzhou 423000, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Hunan University of Chinese Medicine, Changsha 410208, China.
  • Department of Laboratory Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen 518000, China.
  • National & Local Joint Engineering Laboratory for High-through Molecular Diagnosis Technology, the First People's Hospital of Chenzhou, Chenzhou 423000, China.

Zitieren

APA

Zeng, J., Liang, X., Duan, L., Tan, F., Chen, L., Qu, J., Li, J., Li, K., Luo, D., & Hu, Z. (2024). Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023280

Vancouver

Zeng J, Liang X, Duan L, Tan F, Chen L, Qu J, et al. Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2023280

BibTeX
@article{Zeng2024,
  author = {Zeng, Jianling and Liang, Xinquan and Duan, Lili and Tan, Fenghua and Chen, Liujie and Qu, Jiayao and Li, Jia and Li, Kai and Luo, Dixian and Hu, Zheng},
  title = {Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2024},
  doi = {10.3724/abbs.2023280}
}
Kostenlos starten →